Clinical Trials Directory

Trials / Sponsors / Oxford BioMedica

Oxford BioMedica

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Age-Related Macular Degeneration
Phase 12012-08-01
CompletedPhase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
Age Related Macular Degeneration
Phase 12011-02-01
TerminatedTroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Hormone Refractory Prostate Cancer
Phase 22010-08-01
CompletedPhase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopa
Parkinson's Disease
Phase 1 / Phase 22008-01-01
CompletedTroVax Renal Immunotherapy Survival Trial
Clear Cell Renal Carcinoma
Phase 32006-09-01
CompletedSafety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma
Carcinoma, Renal Cell
Phase 22005-11-01
CompletedA Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer
Carcinoma, Renal Cell
Phase 22004-08-01